12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

• Biocept BIOC shares moved upwards by 109.4% to $1.07 during Tuesday's after-market session. Trading volume for this security closed at 4.8 million, accounting for 264.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.8 million.
• Intelligent Bio Solutions INBS shares moved upwards by 31.44% to $0.4. At the close, Intelligent Bio Solutions's trading volume reached 2.0 million shares. This is 1402.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.8 million.
• RVL Pharmaceuticals RVLP stock rose 17.45% to $0.06. RVL Pharmaceuticals's trading volume hit 18.7 million shares by close, accounting for 104.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $6.6 million.
• Virpax Pharmaceuticals VRPX shares rose 14.94% to $0.89. The market value of their outstanding shares is at $10.4 million.
• Exagen XGN shares moved upwards by 8.92% to $1.83. The company's market cap stands at $30.8 million.
• PaxMedica PXMD stock rose 7.61% to $0.26. The market value of their outstanding shares is at $4.4 million.

Losers

• Athersys ATHX shares fell 43.9% to $0.06 during Tuesday's after-market session. Athersys's trading volume hit 45.3 million shares by close, accounting for 2010.9% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.5 million.
• Eiger BioPharmaceuticals EIGR stock fell 9.67% to $0.27. The company's market cap stands at $12.0 million.
• China SXT Pharmaceuticals SXTC shares declined by 7.53% to $2.95. The market value of their outstanding shares is at $1.6 million.
• Ultragenyx Pharmaceutical RARE shares decreased by 6.6% to $34.4. The market value of their outstanding shares is at $2.4 billion.
• Bio-Rad Laboratories BIO stock fell 5.59% to $322.0. The market value of their outstanding shares is at $9.3 billion.
• Inspire Veterinary IVP stock fell 5.49% to $0.86. The company's market cap stands at $10.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.